First Turn Management »

Cabaletta Bio shares owned by First Turn Management

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0M 175k 22.70

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Cabaletta Bio

Jennison Associates
Fred Alger Management
VR Adviser
Vanguard Group
Lynx1 Capital Management
Deerfield Management Company
Perceptive Advisors
Holocene Advisors
Commodore Capital
Redmile Group
Wellington Management Company
T. Rowe Price Associates
Ikarian Capital
Victory Capital Management
Blackstone Group

View all funds holding Cabaletta Bio